Popular News
Life transitions challenge sense of identity
By Delaney F
Elderly find solace in swimming activities
By Brynn Castillo
Good posture may improve mental state
By Brynn Castillo
Doctor says fasting safe for pregnant during eclipse
By Delaney F
World Organ Donation Day Spotlights First 100 Days
By Brynn Castillo
Endometriosis linked to higher diabetes risk
By Delaney F
KAIST chip may improve brain tumor treatment
By Autumn Reeves
Pasir Gudang Hospital to Open Fully December 2026
By Autumn Reeves
Private equity eyes pharma service sector
By Brynn Castillo
Private equity investors target pharma service sector for its benefits.
Axoltis reports positive data for ALS drug
By Autumn Reeves
Grünenthal buys Bayer’s cancer drug Stivarga for €375 million
By Delaney F
Life transitions challenge sense of identity
By Delaney F
Elderly find solace in swimming activities
By Brynn Castillo
Finding magic in everyday life
September 23, 2026
Ant Chloe’s Stories Promote Kindness and Connection for All
September 21, 2026
Writer Highlights Ancient Breathwork and Nasal Breathing Benefits
By Brynn Castillo • Sep 16, 2026
💬 No Comments 🕒 3 Min Read
Understanding Inflammation Risks During Perimenopause
By Brynn Castillo • Sep 12, 2026
💬 No Comments 🕒 3 Min Read
Holistic Practitioners Adopt Upskilling for Enhanced Practice
By Autumn Reeves • Sep 10, 2026
💬 No Comments 🕒 3 Min Read
Daily fiber plays a bigger health role than expected
By Delaney F • Sep 9, 2026
💬 No Comments 🕒 3 Min Read
NICE approves new desmoid tumour treatment
By Delaney F
EU Approves First Treatment for Childhood cALD
By Brynn Castillo
All Post
Americans Question College Value Amid Rising Debt, Job Shifts
Growing debate over college value as 48% of Americans question its ability to prepare students for well-paying jobs amid rising debt.
CHMP Approves Expanded Use of Teclistamab for Myeloma
CHMP approves teclistamab myeloma approval for relapsed/refractory multiple myeloma in adults, following phase 3 results showing improved survival vs standard c
EU Approves First Treatment for Childhood cALD
The EU has approved Nezglyal, the first treatment for childhood cALD, offering a new option for boys aged 2–12 with this aggressive neurodegenerative disease.
UCB’s Start Early program sparks industry shift
The start early program by UCB is sparking an industry shift as clinical research embraces real-world evidence and stronger patient engagement worldwide.
NICE approves new desmoid tumour treatment
NICE recommends Ogsiveo for English adults with progressing desmoid tumours, providing a new targeted treatment option.
Private equity eyes pharma service sector
Private equity investors target pharma service sector for its benefits.
Carvykti therapy yields five-year remissions in early-line myeloma
A single infusion of Carvykti (cilta-cel) kept half of patients with early-line relapsed or refractory multiple myeloma free of disease progression for at.
Axoltis reports positive data for ALS drug
Axoltis reports positive data for ALS drug NX210c, showing reduced decline and target engagement.
Three nations pledge $240 million to fight future pandemics
Three nations pledge $240 million to CEPI’s five-year plan, cutting outbreak risks and ensuring fair vaccine access through accelerated pandemic prevention effo
First Patient Completes Darizmetinib Treatment in Liver Cancer Study
HepaRegeniX's darizmetinib treatment shows positive safety profile in liver cancer study, completing first patient's 28-day cycle.